← Leaderboards
Mark F Lew
University Of Southern California
$1,127,427
Attributed
$1,127,427
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $188.1K · FY2005–14$200K$150K$100K$50K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$1,127,427 · 3
By mechanism
U10$1,127,427 · 1
M01$0 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Southern California
Same institution · by research overlap
- Caryn Lerman$95,133,528
- Christopher Alan Haiman$47,382,319
- Anne L Peters$10,753,617
- Wendy Cozen$10,650,487
- Jane C. Figueiredo$16,710,015
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchClinical TrialsEnrollmentNeurodegenerative DisordersAffectCaliforniaModalityUniversitiesExerciseParkinson DiseaseGeneticEarly DiagnosisGaitEtiologyHuman ActivitiesDopaminergic NeuronAm 80Disease ProgressionAreaAttenuatedBrainDopamineAnimal ModelConduct Clinical Trials
Grant awards (18)
Neuroprotective Clinical Studies in Parkinson's Disease$58,056
U10 · FY2014 · NS · contact PI
Neuroprotective Clinical Studies in Parkinson's Disease$6,802
U10 · FY2014 · NS · contact PI
Neuroprotective Clinical Studies in Parkinson's Disease$104,665
U10 · FY2013 · NS · contact PI
Neuroprotective Clinical Studies in Parkinson's Disease$111,981
U10 · FY2012 · NS · contact PI
Neuroprotective Clinical Studies in Parkinson's Disease$126,010
U10 · FY2011 · NS · contact PI
Neuroprotective Clinical Studies in Parkinson's Disease$145,507
U10 · FY2010 · NS · contact PI
Neuroprotective Clinical Studies in Parkinson's Disease$42,600
U10 · FY2010 · NS · contact PI
Neuroprotective Clinical Studies in Parkinson's Disease$89,092
U10 · FY2009 · NS · contact PI
Neuroprotective Clinical Studies in Parkinson's Disease$73,596
U10 · FY2008 · NS · contact PI
Neuroprotective Clinical Studies in Parkinson's Disease$61,659
U10 · FY2007 · NS · contact PI
Neuroprotective Clinical Studies in Parkinson's Disease$32,500
U10 · FY2006 · NS · contact PI
Neuroprotective Clinical Studies in Parkinson's Disease$32,500
U10 · FY2005 · NS
Neuroprotective Clinical Studies in Parkinson's Disease$123,021
U10 · FY2003 · NS
Neuroprotective Clinical Studies in Parkinson's Disease$119,438
U10 · FY2002 · NS
TRANSDERMAL SPM 962 IN EARLY STAGE PARKINSON'S DISEASE$0
M01 · FY2000 · RR
KW-6002 ADJUNCT THEAPY IN PARKINSON'S DISEASE PTS W MOTOR RESPONSE COMPLICATIONS$0
M01 · FY2000 · RR
KW-6002 ADJUNCT THEAPY IN PARKINSON'S DISEASE PTS W MOTOR RESPONSE COMPLICATIONS$0
M01 · FY2000 · RR
TRANSDERMAL SPM 962 IN EARLY STAGE PARKINSON'S DISEASE$0
M01 · FY2000 · RR